Literature DB >> 28041744

Quantitative Analysis of Contrast-Enhanced Ultrasound Imaging in Invasive Breast Cancer: A Novel Technique to Obtain Histopathologic Information of Microvessel Density.

Naoko Mori1, Shunji Mugikura2, Shoki Takahashi2, Koichi Ito3, Chiaki Takasawa2, Li Li2, Minoru Miyashita4, Atsuko Kasajima5, Yu Mori6, Takanori Ishida4, Tetsuya Kodama7, Kei Takase2.   

Abstract

We examined whether enhancement area ratios obtained by the new bubble detection method correlate with histologic microvessel density in invasive breast cancer. Forty consecutive patients with invasive breast cancer lesions underwent contrast-enhanced ultrasound. The ratio of enhanced area to manually segmented tumor area (enhancement area ratio) was obtained with the new method at peak and delayed phases (50-54, 55-59, 60-64 and 65-69 s). We also analyzed time-intensity curves to obtain peak intensity and area under curve. Enhancement area ratios in both peak and delayed phases (50-54, 55-59, 60-64 and 65-69 s) were significantly correlated with microvessel density (r = 0.57, 0.62, 0.68, 0.61 and 0.58; p = 0.0001, <0.0001, <.0001, <.0001 and 0.0001, respectively). In time-intensity curve analysis, peak intensity was significantly correlated (r = 0.43, p = 0.0073), whereas area under the curve was not (r = 0.29, p = 0.0769). Enhancement area ratios obtained by the new method were correlated with microvessel density in invasive breast cancer.
Copyright © 2016 World Federation for Ultrasound in Medicine & Biology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast cancer; Contrast medium; Microvessels; Quantitative evaluation; Ultrasonography

Mesh:

Substances:

Year:  2016        PMID: 28041744     DOI: 10.1016/j.ultrasmedbio.2016.11.009

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  7 in total

1.  Perfusion contrast-enhanced ultrasound to predict early lymph-node metastasis in breast cancer.

Authors:  Naoko Mori; Shunji Mugikura; Minoru Miyashita; Yumiko Kudo; Mikiko Suzuki; Li Li; Yu Mori; Shoki Takahashi; Kei Takase
Journal:  Jpn J Radiol       Date:  2018-11-20       Impact factor: 2.374

2.  Assessment of angiogenesis in rabbit orthotropic liver tumors using three-dimensional dynamic contrast-enhanced ultrasound compared with two-dimensional DCE-US.

Authors:  Qiao Zheng; Jian-Chao Zhang; Zhu Wang; Si-Min Ruan; Wei Li; Fu-Shun Pan; Li-Da Chen; Yu-Chen Zhang; Wen-Xin Wu; Xiao-Yan Xie; Ming-De Lu; Quan-Yuan Shan; Wei Wang
Journal:  Jpn J Radiol       Date:  2019-08-10       Impact factor: 2.374

3.  Quantitative Multiparametric Breast Ultrasound: Application of Contrast-Enhanced Ultrasound and Elastography Leads to an Improved Differentiation of Benign and Malignant Lesions.

Authors:  Panagiotis Kapetas; Paola Clauser; Ramona Woitek; Georg J Wengert; Mathias Lazar; Katja Pinker; Thomas H Helbich; Pascal A T Baltzer
Journal:  Invest Radiol       Date:  2019-05       Impact factor: 6.016

4.  The quantitative evaluation of contrast-enhanced ultrasound in the differentiation of small renal cell carcinoma subtypes and angiomyolipoma.

Authors:  Hui Liu; Hongli Cao; Lin Chen; Liang Fang; Yingchun Liu; Jia Zhan; Xuehong Diao; Yue Chen
Journal:  Quant Imaging Med Surg       Date:  2022-01

5.  Prediction of neoadjuvant chemotherapy response using diffuse optical spectroscopy in breast cancer.

Authors:  Ying-Hua Yu; Xiao Zhu; Qin-Guo Mo; Ying Cui
Journal:  Clin Transl Oncol       Date:  2017-09-18       Impact factor: 3.405

6.  Clinical evaluation of vascular normalization induced by recombinant human endostatin in nasopharyngeal carcinoma via dynamic contrast-enhanced ultrasonography.

Authors:  Zhendong Yang; Min Kang; Shangyong Zhu; Jianyuan Huang; Xigui Li; Rensheng Wang
Journal:  Onco Targets Ther       Date:  2018-11-08       Impact factor: 4.147

7.  Diagnostic value of radiomics model based on gray-scale and contrast-enhanced ultrasound for inflammatory mass stage periductal mastitis/duct ectasia.

Authors:  Yan Zheng; Lu Bai; Jie Sun; Lin Zhu; Renjun Huang; Shaofeng Duan; Fenglin Dong; Zaixiang Tang; Yonggang Li
Journal:  Front Oncol       Date:  2022-09-20       Impact factor: 5.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.